T1	Participants 73 108	de novo liver transplant recipients
T2	Participants 290 333	de novo liver transplantation (LT) patients
T3	Participants 718 756	Seventy-eight patients were randomized
T4	Participants 1350 1384	monotherapy in de novo LT patients
